What is Yield10 Bioscience?
Headquartered in Woburn, Massachusetts, Yield10 Bioscience operates at the intersection of artificial intelligence and plant genetics. The company is primarily focused on enhancing crop yields and improving the nutritional profile of major commercial food and feed crops. Central to its operational success is the GRAIN (Gene Ranking Artificial Intelligence Network) platform, a proprietary discovery engine that identifies high-value gene targets. By utilizing the Camelina oilseed platform as a rapid testing vehicle, Yield10 effectively bridges the gap between laboratory-based genetic research and large-scale field application, positioning itself as a critical player in the global agricultural supply chain.
How much funding has Yield10 Bioscience raised?
Yield10 Bioscience has raised a total of $119.5M across 4 funding rounds:
Stock Offering
$95.2M
Share Placement
$11.5M
Debt
$150K
Stock Offering
$12.7M
Stock Issuance/Offering (2006): $95.2M, investors not publicly disclosed
Share Placement (2019): $11.5M led by Jack W. Schuler
Debt (2020): $150K supported by PPP
Stock Issuance/Offering (2021): $12.7M, investors not publicly disclosed
Key Investors in Yield10 Bioscience
Jack W. Schuler
A prominent private investor with a history of supporting life sciences and biotechnology ventures.
PPP
Public-Private Partnership
Undisclosed Investors
What's next for Yield10 Bioscience?
With the recent influx of capital, Yield10 Bioscience is well-positioned to accelerate the commercialization of its trait leads. The strategic roadmap involves scaling the deployment of its Camelina-based testing infrastructure to validate new genetic traits that address climate-resilient agriculture. As the company transitions from a research-heavy development phase to a more mature commercial scaling stage, investors will likely monitor the integration of its GRAIN platform into broader agricultural partnerships. The focus remains on achieving long-term sustainability goals while delivering measurable improvements in crop performance for global markets.
See full Yield10 Bioscience company page
